Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia
Multiple sclerosis manifests itself in many different ways and different courses. A recent effort to fine-tune descriptions – or phenotypes—of MS was undertaken by an international team of leaders in MS research and clinical care. The results of this effort by the International Advisory Committee on Clinical Trials in MS, including recommendations for more research, has just been published (Neurology 2014;83:1). The volunteer Committee is jointly supported by the National MS Society and the European Committee for Treatment and Research in MS (ECTRIMS).
"Having better definitions of different types of MS would greatly facilitate research studies, communications between people with MS and their healthcare providers, and treatment decisions," noted Timothy Coetzee, PhD, Chief Advocacy, Services and Research Officer of the National MS Society.
In 1996 the Committee had developed consensus around descriptions of the courses of MS to facilitate research in MS and so that researchers and clinicians around the world would have a common understanding of the types of MS discussed in publications and in the clinic. This consensus highlighted four courses of MS—relapsing-remitting, secondary progressive, primary progressive, and progressive relapsing. While these descriptions of MS have become well-established, understanding of MS has advanced, prompting a re-evaluation of the course of MS and any biological signposts (such as blood markers or imaging) that might help refine these phenotypes.
After a thorough search of the medical literature and convening an international workshop funded by collaborators worldwide (National MS Society, ECTRIMS, Americas Committee for Treatment and Research in MS, MS International Federation, and MS Society of Canada), the Committee published recommendations that modify prior clinical course descriptions. The Committee recommended retaining major courses of MS – relapsing-remitting, secondary-progressive and primary progressive—but recommended categorizing progressive relapsing as an active form of primary progressive MS.
Importantly, they recommended that clinicians not just determine a person's course of MS, but further sub-categorize that course as "active" or "not active" (depending on the presence of clinical relapses or activity on MRI scans) or as progressing (worsening) or not progressing, based on clinical evidence of changes in disability. "This will provide a truer picture of what an individual experiences," added Dr. Coetzee.
"These revisions should make communication with patients and among physicians clearer and should also enhance the design, recruitment and conduct of clinical trials, which will further help us understand the disease," noted Fred D. Lublin, MD, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at The Icahn School of Medicine at Mount Sinai, and the article's lead author.
Areas recommended for further research by the Committee include long-term studies to track people with MS over time, imaging studies to gain a window on brain and spinal cord damage caused by the disease, biomarkers that might differentiate types of MS, and patient-reported outcomes. Researchers funded by the National MS Society and others worldwide are already working toward many of these goals, in efforts to help people with MS live their best lives. In addition, this information will be considered by the Society's leadership as it develops future research strategies.
Explore further: Researchers lead committee to define the clinical course of multiple sclerosis
More information: The free-access paper is now available on the Neurology website: http://ift.tt/1x6xcX8
Medical Xpress on facebook
Related Stories
Researchers lead committee to define the clinical course of multiple sclerosis
May 28, 2014
Accurate clinical course descriptions (phenotypes) of multiple sclerosis (MS) are important for communication, prognostication, design and recruitment for clinical trials, and treatment decision-making. Researchers at Icahn ...
Statins slow the progression of advanced multiple sclerosis in clinical trial
Mar 18, 2014
Statins may provide doctors with an unlikely new weapon with which to slow the progression of multiple sclerosis (MS).
No apparent link between chronic cerebrospinal venous insufficiency and MS
Jun 02, 2014
There appears to be no link between chronic cerebrospinal venous insufficiency and multiple sclerosis (MS), according to new research published in CMAJ (Canadian Medical Association Journal).
Imaging scientists develop a better tool for tracking MS
May 27, 2014
Imaging scientists at Western University's Robarts Research Institute (London, Canada) have developed a better way to track the progression of Multiple Sclerosis (MS) from its earliest stages. Led by Ravi ...
Low-fat diet helps fatigue in people with multiple sclerosis
May 01, 2014
People with multiple sclerosis who for one year followed a plant-based diet very low in saturated fat had much less MS-related fatigue at the end of that year—and significantly less fatigue than a control group of people ...
Recommended for you
Regulating brain activity to improve attention
30 minutes ago
(Medical Xpress)—Researchers from The University of Nottingham have found that balanced activity in the brain's prefrontal cortex is necessary for attention.
The beautiful brain cells you don't know about
1 hour ago
The number of nerve cells in the human brain sounds impressive: 100 billion. And it is.
Complex neural circuitry keeps you from biting your tongue
17 hours ago
Eating, like breathing and sleeping, seems to be a rather basic biological task. Yet chewing requires a complex interplay between the tongue and jaw, with the tongue positioning food between the teeth and ...
Probing the limits to memory
18 hours ago
(Medical Xpress)—There is no mystery in the way that computers store information. It is straightforward to determine how much memory they have and what is contained in that memory. Brains don't really have ...
Stress hormone receptors localized in sweet taste cells
19 hours ago
According to new research from the Monell Center, receptors for stress-activated hormones have been localized in oral taste cells responsible for detection of sweet, umami, and bitter. The findings suggest ...
Researchers find spatial awareness shifts right as people fall asleep
20 hours ago
(Medical Xpress)—A team of researchers working at Cambridge University in the U.K. has found that spatial awareness shifts to the right when people are falling asleep. In their paper published in the journal ...
User comments
© Medical Xpress 2011-2014, Science X network
Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia
Multiple sclerosis manifests itself in many different ways and different courses. A recent effort to fine-tune descriptions – or phenotypes—of MS was undertaken by an international team of leaders in MS research and clinical care. The results of this effort by the International Advisory Committee on Clinical Trials in MS, including recommendations for more research, has just been published (Neurology 2014;83:1). The volunteer Committee is jointly supported by the National MS Society and the European Committee for Treatment and Research in MS (ECTRIMS).
"Having better definitions of different types of MS would greatly facilitate research studies, communications between people with MS and their healthcare providers, and treatment decisions," noted Timothy Coetzee, PhD, Chief Advocacy, Services and Research Officer of the National MS Society.
In 1996 the Committee had developed consensus around descriptions of the courses of MS to facilitate research in MS and so that researchers and clinicians around the world would have a common understanding of the types of MS discussed in publications and in the clinic. This consensus highlighted four courses of MS—relapsing-remitting, secondary progressive, primary progressive, and progressive relapsing. While these descriptions of MS have become well-established, understanding of MS has advanced, prompting a re-evaluation of the course of MS and any biological signposts (such as blood markers or imaging) that might help refine these phenotypes.
After a thorough search of the medical literature and convening an international workshop funded by collaborators worldwide (National MS Society, ECTRIMS, Americas Committee for Treatment and Research in MS, MS International Federation, and MS Society of Canada), the Committee published recommendations that modify prior clinical course descriptions. The Committee recommended retaining major courses of MS – relapsing-remitting, secondary-progressive and primary progressive—but recommended categorizing progressive relapsing as an active form of primary progressive MS.
Importantly, they recommended that clinicians not just determine a person's course of MS, but further sub-categorize that course as "active" or "not active" (depending on the presence of clinical relapses or activity on MRI scans) or as progressing (worsening) or not progressing, based on clinical evidence of changes in disability. "This will provide a truer picture of what an individual experiences," added Dr. Coetzee.
"These revisions should make communication with patients and among physicians clearer and should also enhance the design, recruitment and conduct of clinical trials, which will further help us understand the disease," noted Fred D. Lublin, MD, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at The Icahn School of Medicine at Mount Sinai, and the article's lead author.
Areas recommended for further research by the Committee include long-term studies to track people with MS over time, imaging studies to gain a window on brain and spinal cord damage caused by the disease, biomarkers that might differentiate types of MS, and patient-reported outcomes. Researchers funded by the National MS Society and others worldwide are already working toward many of these goals, in efforts to help people with MS live their best lives. In addition, this information will be considered by the Society's leadership as it develops future research strategies.
Explore further: Researchers lead committee to define the clinical course of multiple sclerosis
More information: The free-access paper is now available on the Neurology website: http://ift.tt/1x6xcX8
Medical Xpress on facebook
Related Stories
Researchers lead committee to define the clinical course of multiple sclerosis
May 28, 2014
Accurate clinical course descriptions (phenotypes) of multiple sclerosis (MS) are important for communication, prognostication, design and recruitment for clinical trials, and treatment decision-making. Researchers at Icahn ...
Statins slow the progression of advanced multiple sclerosis in clinical trial
Mar 18, 2014
Statins may provide doctors with an unlikely new weapon with which to slow the progression of multiple sclerosis (MS).
No apparent link between chronic cerebrospinal venous insufficiency and MS
Jun 02, 2014
There appears to be no link between chronic cerebrospinal venous insufficiency and multiple sclerosis (MS), according to new research published in CMAJ (Canadian Medical Association Journal).
Imaging scientists develop a better tool for tracking MS
May 27, 2014
Imaging scientists at Western University's Robarts Research Institute (London, Canada) have developed a better way to track the progression of Multiple Sclerosis (MS) from its earliest stages. Led by Ravi ...
Low-fat diet helps fatigue in people with multiple sclerosis
May 01, 2014
People with multiple sclerosis who for one year followed a plant-based diet very low in saturated fat had much less MS-related fatigue at the end of that year—and significantly less fatigue than a control group of people ...
Recommended for you
Regulating brain activity to improve attention
30 minutes ago
(Medical Xpress)—Researchers from The University of Nottingham have found that balanced activity in the brain's prefrontal cortex is necessary for attention.
The beautiful brain cells you don't know about
1 hour ago
The number of nerve cells in the human brain sounds impressive: 100 billion. And it is.
Complex neural circuitry keeps you from biting your tongue
17 hours ago
Eating, like breathing and sleeping, seems to be a rather basic biological task. Yet chewing requires a complex interplay between the tongue and jaw, with the tongue positioning food between the teeth and ...
Probing the limits to memory
18 hours ago
(Medical Xpress)—There is no mystery in the way that computers store information. It is straightforward to determine how much memory they have and what is contained in that memory. Brains don't really have ...
Stress hormone receptors localized in sweet taste cells
19 hours ago
According to new research from the Monell Center, receptors for stress-activated hormones have been localized in oral taste cells responsible for detection of sweet, umami, and bitter. The findings suggest ...
Researchers find spatial awareness shifts right as people fall asleep
20 hours ago
(Medical Xpress)—A team of researchers working at Cambridge University in the U.K. has found that spatial awareness shifts to the right when people are falling asleep. In their paper published in the journal ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment